Skip to main
PACS

PACS Stock Forecast & Price Target

PACS Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PACS Group is well-positioned for strong future growth due to its leading scale and positioning in the post-acute care industry, as well as its strategic focus on acquisitions and real estate expansion. Despite potential risks such as government reimbursement and labor costs, the company's positive financial outlook, driven by increasing adjusted EBITDA and EPS estimates, makes it a promising investment opportunity.

Bears say

PACS Group is a post-acute healthcare company in a growing market with favorable demographics and industry tailwinds, but we have a negative outlook due to concerns about the company's strategy of acquiring underperforming facilities and relying on a decentralized model. Furthermore, the fragmented market and competitive landscape may hinder the company's ability to maintain attractive quality and operational metrics. As a result, we do not see a strong competitive advantage or potential for significant growth in earnings or shareholder value.

PACS has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PACS Group, Inc. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PACS Group, Inc. (PACS) Forecast

Analysts have given PACS a Buy based on their latest research and market trends.

According to 5 analysts, PACS has a Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $50.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $50.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PACS Group, Inc. (PACS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.